Paul Tudor Jones’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-48,244
| Closed | -$3.63M | – | 3911 |
|
|
2026
Q1 | $3.62M | Buy |
48,244
+44,583
| +1,218% | +$3.52M | 0.01% | 1407 |
|
|
2025
Q4 | $290K | Buy |
+3,661
| New | +$276K | ﹤0.01% | 3077 |
|
|
2024
Q4 | – | Sell |
-53,479
| Closed | -$2M | – | 3246 |
|
|
2024
Q3 | $2.14M | Buy |
53,479
+40,381
| +308% | +$1.88M | 0.01% | 1162 |
|
|
2024
Q2 | $624K | Buy |
+13,098
| New | +$537K | ﹤0.01% | 1703 |
|
|
2023
Q3 | – | Sell |
-39,025
| Closed | -$1.6M | – | 2556 |
|
|
2023
Q2 | $1.6M | Sell |
39,025
-33,552
| -46% | -$1.29M | 0.02% | 1019 |
|
|
2023
Q1 | $2.59M | Buy |
72,577
+36,212
| +100% | +$1.36M | 0.04% | 651 |
|
|
2022
Q4 | $1.37M | Buy |
36,365
+15,256
| +72% | +$642K | 0.03% | 872 |
|
|
2022
Q3 | $934K | Sell |
21,109
-53,083
| -72% | -$2.24M | 0.02% | 963 |
|
|
2022
Q2 | $2.75M | Buy |
74,192
+44,667
| +151% | +$1.68M | 0.07% | 367 |
|
|
2022
Q1 | $1.09M | Sell |
29,525
-148,861
| -83% | -$4.87M | 0.03% | 867 |
|
|
2021
Q4 | $5.43M | Sell |
178,386
-23,227
| -12% | -$731K | 0.09% | 243 |
|
|
2021
Q3 | $6.76M | Buy |
201,613
+101,727
| +102% | +$3.83M | 0.11% | 182 |
|
|
2021
Q2 | $3.98M | Buy |
+99,886
| New | +$3.91M | 0.08% | 302 |
|
|
2020
Q4 | – | Sell |
-44,644
| Closed | -$2.12M | – | 1464 |
|
|
2020
Q3 | $2.12M | Buy |
+44,644
| New | +$2.48M | 0.09% | 276 |
|
|
2020
Q2 | – | Sell |
-11,546
| Closed | -$546K | – | 1281 |
|
|
2020
Q1 | $546K | Buy |
+11,546
| New | +$644K | 0.05% | 461 |
|
|
2019
Q3 | – | Sell |
-14,576
| Closed | -$937K | – | 1209 |
|
|
2019
Q2 | $937K | Buy |
14,576
+12,042
| +475% | +$851K | 0.03% | 530 |
|
|
2019
Q1 | $206K | Sell |
2,534
-10,601
| -81% | -$684K | 0.01% | 994 |
|
|
2018
Q4 | $710K | Buy |
+13,135
| New | +$670K | 0.01% | 488 |
|
|
2016
Q3 | – | Sell |
-9,100
| Closed | -$212K | – | 1566 |
|
|
2016
Q2 | $212K | Buy |
+9,100
| New | +$294K | ﹤0.01% | 1374 |
|
|
2015
Q3 | – | Sell |
-32,507
| Closed | -$1.87M | – | 1633 |
|
|
2015
Q2 | $1.87M | Buy |
32,507
+26,117
| +409% | +$1.66M | 0.05% | 214 |
|
|
2015
Q1 | $407K | Sell |
6,390
-83
| -1% | -$5.63K | 0.01% | 862 |
|
|
2014
Q4 | $400K | Buy |
+6,473
| New | +$319K | 0.01% | 867 |
|
Other funds holding IONS
Paul Tudor Jones's IONS Position: Q2 2026 in Review
Paul Tudor Jones sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 48,244 shares — an estimated $3.63M sold.
Paul Tudor Jones first reported a position in IONS in Q4 2014 and held it in 22 quarters. The position peaked at $6.76M in Q3 2021. 510 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Paul Tudor Jones reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Paul Tudor Jones sold 48,244 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.63M.
- Paul Tudor Jones first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 22 quarters.
- Paul Tudor Jones's Ionis Pharmaceuticals position peaked at $6.76M in Q3 2021.
- 510 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.